Baseline [18F]FDG PET/CT radiomics for predicting interim efficacy in follicular lymphoma treated with first-line R-CHOP
Our preliminary results demonstrate that a radiomics-clinical combined model, based on baseline [<sup>18</sup>F]FDG PET/CT radiomics features and clinical risk factors, may contribute to predicting interim efficacy in FL patients.
Authors
- Jianwei Yang (ORCID: https://orcid.org/0000-0003-2536-2334)
- Qingxia Wu (ORCID: https://orcid.org/0000-0003-4888-8830)
- Zeying Wen (ORCID: https://orcid.org/0000-0002-0270-6694)
- Yanmei Li (ORCID: https://orcid.org/0000-0003-2116-1607)
- Xīn Gào (ORCID: https://orcid.org/0000-0003-0108-6961)
- Jian Sun (ORCID: https://orcid.org/0000-0003-0067-5967)
- Ruihua Wang (ORCID: https://orcid.org/0000-0002-4020-8039)
- Hongfei Zhao (ORCID: https://orcid.org/0000-0001-9691-519X)
- Kalung Wu
Institutions
- Zhengzhou University (CN)
- United Imaging Healthcare (China) (CN)
- Henan Cancer Hospital (CN)
- First Affiliated Hospital of Henan University (CN)
- First Affiliated Hospital of Zhengzhou University (CN)
Publication Details
- Journal
- BMC Cancer
- Published
- 2025-01-23
- DOI
- https://doi.org/10.1186/s12885-025-13507-3
- Citations
- 4
- Primary Topic
- Lymphoma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 5.89